Kinvent Inc.

Kinvent develops connected biomechanical assessment devices and software for rehabilitation, sports performance, clinical diagnosis, and research. The company specializes in real-time measurement of strength, balance, mobility, and neuromuscular function through a suite of portable, sensor-based products. Their device portfolio includes force plates (K-Deltas, K-Deltas XL, 3D Deltas, K-Force Plates), handheld and fixed dynamometers (K-Push, K-Pull, K-Grip, K-Bubble), motion sensors (K-Move for goniometry, K-Power for gait and speed analysis), and surface EMG sensors (K-Myo). All devices integrate with a HIPAA-compliant software platform for data capture, analysis, and patient progress tracking. Kinvent targets physical therapists, sports performance coaches, physicians, orthopedic specialists, and researchers. The platform supports objective assessments for return-to-sport testing, rehabilitation outcome measurement, injury prevention, and performance optimization. The company serves professional sports teams (including MLB's Cleveland Guardians), academic medical centers (Hospital for Special Surgery, Weill Cornell Medicine, Stanford Health Care), and research institutions. Products are used for ACL rehabilitation, lower-back pain assessment, ankle sprain management, gait analysis, vertical jump assessment, grip strength evaluation, and neuromuscular symmetry testing.